Quarterly ResultJun 26, 2026, 07:02 AM
Beyond Air FY26 Revenue +107% to $7.7M; Guides FY27 Revenue $16-18M
AI Summary
Beyond Air, Inc. announced strong financial results for fiscal year 2026, with revenue increasing 107% to $7.7 million, driven by demand for LungFit PH. The company provided optimistic revenue guidance of $16-$18 million for calendar year 2027, anticipating significant growth from the potential FDA approval of its second-generation LungFit PH system. However, the company reported a net loss of $33.2 million for FY2026 and implemented a 1-for-20 reverse stock split to maintain Nasdaq listing compliance.
Key Highlights
- Fiscal Year 2026 revenue increased 107% to $7.7 million.
- Fiscal Fourth Quarter 2026 revenue increased 66% to $1.9 million.
- Fiscal Year 2026 net loss was $33.2 million, or ($4.01) per share.
- Fiscal Year 2027 revenue guidance is $16-$18 million, representing over 110% growth.
- Second-generation LungFit PH under FDA review; expected to increase U.S. market to $400M.
- Robert Goodman appointed CEO and Dan Moorhead appointed CFO in early 2026.
- Board approved 1-for-20 reverse stock split to regain Nasdaq compliance.
- Company is transitioning its fiscal year-end from March 31st to December 31st.
Price Impact
More from XAIR